Mori Seijiro
Center for the Promotion of Clinical Investigation, Tokyo Metropolitan Geriatric Hospital, Japan.
Clin Calcium. 2017;27(7):917-923.
Quantitative as well as qualitative bone loss occurs with aging in both men and women, leading to alterations in skeletal microarchitecture and increased fracture incidence. Sex steroids, primarily estrogen and testosterone, have been shown to play a central role in the aging process of bone. The relationship between diminishing estrogen levels in women caused by ovarian failure and the development of postmenopausal osteoporosis is widely recognized. Unexpectedly, bone mineral density at various skeletal sites in men is also better correlated with circulating levels of bioavailable estrogen than with testosterone. Recently, it is also suggested that senescent osteocytes and their senescence-associated secretory phenotype may contribute to age-related bone loss. Osteoporosis should be considered as a disease developing on the basis of the natural aging process which is modified to some degree by various genetic and environmental factors.
随着年龄增长,男性和女性都会出现骨质流失,包括定量和定性的骨质流失,这会导致骨骼微结构改变以及骨折发生率增加。性激素,主要是雌激素和睾酮,已被证明在骨骼衰老过程中起核心作用。卵巢功能衰竭导致女性雌激素水平下降与绝经后骨质疏松症的发生之间的关系已广为人知。出乎意料的是,男性不同骨骼部位的骨矿物质密度与循环中生物可利用雌激素水平的相关性也比与睾酮的相关性更好。最近,也有人提出衰老的骨细胞及其衰老相关分泌表型可能导致与年龄相关的骨质流失。骨质疏松症应被视为一种在自然衰老过程基础上发展的疾病,各种遗传和环境因素会在一定程度上对其产生影响。